Capital Fund Management (CFM)
HALO icon

Capital Fund Management (CFM)’s Halozyme HALO Stock Holding History

Capital Fund Management (CFM)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,700
Closed -$543K – 2092
2023
Q4 		$543K Sell
14,700
-500
-3% -$18.8K ﹤0.01% 1973
2023
Q3 		$581K Buy
+15,200
New +$623K ﹤0.01% 1769

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Capital Fund Management (CFM)'s HALO Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Halozyme (HALO) stake by 52% in Q2 2026, selling an estimated $6.14M and leaving 84,367 shares worth $6.6M. The position accounts for 0.03% of the portfolio, ranked #783.

Capital Fund Management (CFM) first reported a position in HALO in Q2 2013 and has held it in 14 quarters since. The position peaked at $15.6M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Capital Fund Management (CFM) held 84,367 shares of Halozyme worth $6.6M as of Q2 2026.
  • Capital Fund Management (CFM) sold 90,011 Halozyme shares in Q2 2026, an estimated $6.14M.
  • Halozyme made up 0.03% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #783 holding.
  • Capital Fund Management (CFM) first reported a position in Halozyme in Q2 2013 and has held it in 14 quarters since.
  • Capital Fund Management (CFM)'s Halozyme position peaked at $15.6M in Q3 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.